Portig Irene, Hofacker Elena, Sommer Philipp, Volberg Christian, Seifart Carola
Research Group Medical Ethics, Faculty of Medicine, Philipps University of Marburg, Baldingerstraße, 35043, Marburg, Germany.
Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, University Hospital of Ruhr University Bochum, Bad Oeynhausen, Germany.
Clin Res Cardiol. 2024 Sep 2. doi: 10.1007/s00392-024-02525-z.
The patient's right to refuse pacemaker therapy is mentioned in the relevant European consensus statement but additional information is only available on deactivation of implantable cardioverter deactivator and not on other cardiac implantable electronic devices such as pacemakers. Therefore, we were interested in opinions, concerns and attitudes of cardiologists, who are the primary contact persons for such requests, since the number of patients asking for withdrawal of pacemaker therapy is likely to increase leaving cardiologists and healthcare professionals with a difficult medical but also ethical problem.
An anonymous questionnaire was sent to all German cardiology departments (N = 288).
48% of cardiology departments responded by sending back 247 completed questionnaires. Most participating cardiologists were experienced when considering the duration of their professional activity. Almost all of the respondents regularly perform check-ups of pacemakers. The majority of cardiologists answering our questionnaire were prepared to deactivate a pacemaker upon patients' request, and have done so. In pacemaker dependency, however, the willingness to withdraw decreases, even if death is imminent, for fear of causing distressing symptoms, sense of being responsible for patients possible immediate death, or fear of legal consequences.
The survey could clearly show that uncertainties remain among cardiologists dealing with a patient's wish for withdrawal, especially in cases of pacemaker dependency. We suggest that official statements of cardiologic societies in Europe are issued to clarify ethical, legal and practical aspects of pacemaker withdrawal.
Registered in the German Clinical Trials Register (DRKS00026168) on 30.08.2021.
欧洲相关共识声明中提到了患者拒绝起搏器治疗的权利,但关于可植入式心律转复除颤器停用的额外信息仅有报道,而对于起搏器等其他心脏植入式电子设备并无相关信息。因此,鉴于要求撤回起搏器治疗的患者数量可能会增加,这给心脏病专家和医疗保健专业人员带来了棘手的医学和伦理问题,我们对作为此类请求主要联系人的心脏病专家的意见、担忧和态度感兴趣。
向德国所有心脏病学部门(N = 288)发送了一份匿名问卷。
48%的心脏病学部门回复,共返回247份完整问卷。考虑到他们的专业活动时长,大多数参与调查的心脏病专家经验丰富。几乎所有受访者都定期对起搏器进行检查。回答我们问卷的大多数心脏病专家准备应患者要求停用起搏器,并且已经这样做过。然而,在起搏器依赖的情况下,撤回治疗的意愿会降低,即使患者即将死亡,因为担心引发痛苦症状、对患者可能立即死亡负有责任,或担心法律后果。
调查清楚地表明,在处理患者撤回治疗愿望的心脏病专家中仍存在不确定性,尤其是在起搏器依赖的情况下。我们建议欧洲心脏病学会发布官方声明,以阐明撤回起搏器的伦理、法律和实际问题。
于2021年8月30日在德国临床试验注册中心(DRKS00026168)注册。